Laboratoires SMB S.A.
Privately held: no public share price · Belgium
Assets
(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
PravafenixNo recent activity | Phase 3 | HMG-CoA reductase / PPAR-alphaSmall molecule | Atherosclerotic Cardiovascular DiseaseCardiovascular Disease / Dyslipidemia Hypertriglyceridemia |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.